RxDoctor Payments Data

Melissa Herrman, MD

Family Medicine · Topeka, KSNPI 1184750796

Payments from drug & device makers

$560in general payments, 2019–2025

Across 45 payments — averaging $12.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$130
  • Lilly USA, LLC$99
  • Amgen$65
  • GSK$40
  • Regeneron Healthcare Solutions, Inc.$28
  • Ironwood Pharmaceuticals, Inc$27
  • plus $171 from 9 others

What the payments were for

  • Food & beverage$560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$560 in reported general payments places this provider in the 50th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$188,305
Medicare patients
483
Services billed
3,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$57,793
JardianceEmpagliflozin62$54,063
EliquisApixaban63$39,784
TrulicityDulaglutide23$32,917
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$29,550
MyrbetriqMirabegron32$21,882
OxycontinOxycodone Hcl23$18,641
XareltoRivaroxaban28$16,306
Incruse ElliptaUmeclidinium Bromide38$13,681
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$11,651
MounjaroTirzepatide11$11,494
Spiriva RespimatTiotropium Bromide16$11,457
JanuviaSitagliptin Phosphate11$10,854
LinzessLinaclotide18$9,557
FarxigaDapagliflozin Propanediol16$9,105

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$14$65,52078 claims
Novo NordiskOzempic$130$57,79336 claims
GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta$40$54,88395 claims
Lilly USA, LLCTrulicity, Mounjaro$99$44,41134 claims
MerckJanuvia, Janumet Xr$17$16,79922 claims
Johnson & JohnsonXarelto$25$16,30628 claims
AbbVieLinzess$24$9,55718 claims
AstraZenecaFarxiga$27$9,10516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Topeka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →